An IHC study analysing 445 NSCLC patients demonstrated that those with positive expression of both GLUT1 and PKM2 (G+/P+) had significantly poorer overall and disease-free survival rates following curative R0 resection [115]. This evidence concerns the gene SLC2A1 and non-small cell lung carcinoma.